Projects

01.07.2025 – 31.12.2027

Development of a novel in vitro diagnostic tool for the initial differentiation and monitoring of virulent and temperate Pseudomonas phages in human samples.

01.01.2025 – 31.12.2027

Research into a diagnostic method for detecting non-tuberculous mycobacterial infections.

01.01.2025 – 30.06.2027

Development of a monitoring method for people with weakened immune systems through the first-ever quantification of immune status using an EliSpot assay.

01.10.2024 – 31.03.2027

Development of an optomechanical detection system for speckle-based germ detection.

01.11.2022 – 31.10.2025

Development of HPV assays that improve cervical cancer screening and contribute to better cancer prevention and treatment.

01.06.2021 – 31.05.2024

Predicting the individual immune response to organ transplants.

01.07.2020 – 31.12.2022

Innovative lighting for multispectral fluorescence imaging analysis.

01.04.2018 – 31.03.2021

Test system for identifying autoreactive T cells to improve the diagnosis of multiple sclerosis.

01.01.2017 – 31.12.2020

A multicentre Phase II trial investigating the use of HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischaemia, accompanied by mechanistic studies.

01.04.2016 – 31.03.2018

Development of an optical, marker-free method for the automated detection of the cytopathic effect as the basis for a high-throughput method for researching and standard-compliant testing of the virucidal potency of disinfectants.
 

01.02.2014 – 30.04.2016

Development of an image-processing-based analyser for the automated evaluation of Legionella tests on agar plates.

01.11.2012-30.10.2018

Personalised minimisation of immunosuppression following organ transplantation through biomarker-based patient stratification to improve long-term outcomes and health economic data.
 

01.07.2012-30.06.2015

EliSpot test system for monitoring HPV vaccination and developing new vaccine and treatment approaches.

01.11.2009-29.02.2012

Development and validation of a B cell EliSpot assay for the detection of antibody-secreting cells in immunosuppressed/vaccinated patients.
 

 01.06.2008-31.05.2011

KMU-innovativ Excellence Cluster: “Development of a diagnostic test system for the comprehensive assessment of infectious diseases (‘IFL-EliSpot’)”.